You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Salvage therapy in DLBCL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma Trial (Polatuzumab Vedotin)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Polatuzumab Vedotin
  • (no location specified)
May 3, 2022

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Hangzhou (Sintilimab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 2, 2020

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Surgical Flap, Negative-Pressure Dressings Trial in Aswan (NPWT, Conventional dressing)

Active, not recruiting
  • Surgical Flap
  • Negative-Pressure Dressings
  • NPWT
  • Conventional dressing
  • Aswan, Egypt
    Aswan University Hospital
Oct 12, 2023

Toxicities of Salvage Treatment in Locoregionally Recurrent

Not yet recruiting
  • Breast Cancer
  • Salvage treatment (surgery and/or radiation therapy)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 5, 2023

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Relapsed Diffuse Large B-cell Lymphoma, Refractory DLBCL Trial in Worldwide (Polatuzumab Vedotin, Mabthera, Ifosfamide)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +4 more
  • Graz, Austria
  • +62 more
Aug 2, 2022

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Itacitinib
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Tampa, Florida
    Moffitt Cancer Center
Mar 6, 2023

Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • External Beam Radiation Therapy
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

Recurrent Epithelial Ovarian Cancer Trial in Seoul (Standard salvage therapy, Standard salvage therapy + SABR)

Recruiting
  • Recurrent Epithelial Ovarian Cancer
  • Standard salvage therapy
  • Standard salvage therapy + SABR
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 29, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Recurrent Prostate Cancer Trial in Bern (Ultrahypofractionated salvage radiotherapy to a local recurrence after radical

Recruiting
  • Recurrent Prostate Cancer
  • Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy
  • Androgen deprivation therapy
  • Bern, Switzerland
    Inselgruppe AG, Inselspital
Mar 1, 2023

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Omaha, Nebraska
  • +4 more
Nov 10, 2022

Sarcoma, Ewing, Sarcoma Trial in Santa Monica (Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus

Active, not recruiting
  • Sarcoma, Ewing
  • Sarcoma
  • Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
  • Santa Monica, California
    Sarcoma Oncology Research Center
Jan 19, 2023

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

DLBCL - Diffuse Large B Cell Lymphoma Trial in Toronto (Cyclophosphamide, TLI)

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 19, 2023

Endovascular Limb Salvage in Trinidad and Tobago

Completed
  • Limb Salvage Rates With Endovascular Therapy
  • Endovascular revascularisation
  • Port Of Spain, North Central, Trinidad and Tobago
    Eric Williams Medical Sciences Complex
Sep 15, 2022

Prostate Cancer Trial (Early salvage radiotherapy (eSRT), Delayed Salvage radiotherapy (dSRT))

Not yet recruiting
  • Prostate Cancer
  • Early salvage radiotherapy (eSRT)
  • Delayed Salvage radiotherapy (dSRT)
  • (no location specified)
Aug 2, 2022

Frontline of ASCT in High-risk DLBCL

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Apr 26, 2023

    Multiple Myeloma Trial in Houston (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 5, 2023

    Cervical Cancer Trial in Chongqing (salvage surgery)

    Recruiting
    • Cervical Cancer
    • salvage surgery
    • Chongqing, Chongqing, China
      Chongqing Cancer Hospital
    Feb 20, 2023

    Head Neck Cancer Trial in Detroit, Cincinnati (Nivolumab)

    Active, not recruiting
    • Head and Neck Cancer
    • Detroit, Michigan
    • +1 more
    Oct 3, 2022